Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05272475 · ClinicalTrials.gov registry record · NA
The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05272475 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 8 participants.
The verdict
NCT05272475, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized complete crossover study will investigate the impact of chamomile ingestion acutely on coagulation.
Interventions
- DIETARY_SUPPLEMENT Chamomile Tea
- DIETARY_SUPPLEMENT Chamomile Extract Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-03-16 |
| Est. Completion | 2022-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05272475
The ClinicalTrials.gov registry entry for NCT05272475 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chamomile Tea is the first listed.
NCT05272475 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05272475 about?
NCT05272475 is a clinical study titled "The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers". Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized complete crossover study will investigate the impact of chamomile ingestion acutely on coagulation.
What is the current status of trial NCT05272475?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-03-16. Estimated completion is 2022-05-12.
What interventions are being tested in trial NCT05272475?
The interventions under investigation include: Chamomile Tea (DIETARY_SUPPLEMENT), Chamomile Extract Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05272475?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.